SCHEMBL3885537

SCHEMBL3885537

CCC(=O)N1CCN(c2nc(-c3ccc(F)c(Cl)c3)cc(N3CCN(c4ncccc4C(F)(F)F)CC3)n2)CC1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 3/20 0.47
TRPA1 O75762 1/20 0.46
TRPV1 Q8NER1 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GALR2 O43603 4/20 0.45
GALR1 P47211 4/20 0.45
GAA P10253 1/20 0.44
HSD11B1 P28845 3/20 0.43
GBA1 P04062 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3879411 0.91 TRPA1 (0.47) RBP4TRPA1TRPV1ALDH1A1GALR2
SCHEMBL3880207 0.89 GALR2 (0.51) TRPV1GALR2GALR1HSD11B1
SCHEMBL3880931 0.88 GALR2 (0.46) RBP4TRPA1TRPV1GALR2GALR1
SCHEMBL3880010 0.88 GALR2 (0.47) TRPV1GALR2GALR1HSD11B1
SCHEMBL3885408 0.87 GALR2 (0.55) TRPV1GALR2GALR1HSD11B1
SCHEMBL3877834 0.87 GALR2 (0.55) TRPV1GALR2GALR1HSD11B1
SCHEMBL3876390 0.86 GALR2 (0.46) TRPV1GALR2GALR1HSD11B1
SCHEMBL3876607 0.86 GALR2 (0.56) TRPV1GALR2GALR1HSD11B1
SCHEMBL3887137 0.85 GALR2 (0.43) RBP4TRPA1TRPV1ALDH1A1GALR2
SCHEMBL3876780 0.85 GALR2 (0.46) RBP4TRPA1TRPV1GALR2GALR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed